D-1403-2015 Class II Terminated

Recalled by Liberty Drug & Surgical — Chatham, NJ

FDA drug recall D-1403-2015 was initiated by Liberty Drug & Surgical on Jun 15, 2015 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product. The recall status is terminated (terminated Apr 23, 2018). Affected quantity: 5 vials.

Recall details

Product Type
Drugs
Report Date
Sep 2, 2015
Initiation Date
Jun 15, 2015
Termination Date
Apr 23, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 vials

Product description

Lidocaine/Sodium Chloride 0.4%/20% Injectable, 5 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.

Reason for recall

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Distribution pattern

Physicians, Medical Facilities, and Prescription Specific Patients in NJ and NY

Code information

Lot #: 05072015@4, Exp 06/21/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1403-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1403-2015. Report a data issue: hello@regdatalab.com.